Covid-19 Coronavirus Clinical Trials around the World

Covid-19, Coronavirus Clinical Trials Worldwide

With the pandemic of Covid-19 continuing across the globe, pharmaceutical companies, scientists, hospitals and health care organizations around the world continue to accelerate clinical research to find a treatment and possible vaccine.

The number of Covid-19, coronavirus clinical trials has been steadily growing since January 2020. As of March 31st, there are 287 active Clinical Trials around the world focused on Covid-19.

These Clinical Trials are being conducted across most regions of the world; Europe has 100 going on, Asia has 79 and North America has 56. Within each of these regions we can also find the number of Covid-19 Clinical Trials by Country.

We expect further growth over the next few months in the number of Clinical Trials for Covid-19 around the world. We will publish any updates as data of new Clinical Trials are made available.

We are actively consulting on how to successfully fast-track market access of health product developed for addressing the current pandemic. Communicate with us to see how we can help.

Download a Covid-19 Clinical Trial summary report

We have co-published a report on Covid-19 Clinical Trials with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions
# of Covid-19 Clinical Trials that have been completed

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Mise à jour des vaccins Covid-19 2021

2021 Covid-19 Vaccines Update

In December we published a report on up and coming Covid-19 Vaccines from around the world. This month we are publishing an update on approved Covid 19 Vaccines and promising Covid-19 Vaccine candidates that have reached phase 3 clinical trials. We have indicated background information, Trial Design, their status for each.

This report is co-published with the Clinical Research Consultancy CRO, McDougall Scientific and provided to you in a format that is hopefully useful to digest. All clinical trial data, summaries, content and references have been referenced directly from clinicaltrials.gov provided by the National Institutes of Health, by the Regulatory Affairs Professionals Society (RAPS), the New York Times Coronavirus Vaccine Tracker, and by CNN Health.

Download the 2021 Covid-19 Vaccines report

DOWNLOAD NOW

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Vaccines Summary

Over the course of the year, we have published reports on active Covid-19 clinical trials in Canada and from around the world. This month we are publishing a summary report of promising Covid-19 Vaccines. Researchers are racing to produce a safe and effective coronavirus vaccine against the COVID-19 pandemic.

In this report, we have summarized the status of 11 promising vaccine candidates that have reached phase 3 clinical trials. We have indicated each candidate’s Trial Design, their outcomes and overall status.

This report is co-published with the Clinical Consultancy CRO, McDougall Scientific and provided to you in a format that is hopefully useful to digest.

All clinical trial data, summaries, content and references have been referenced directly from clinicaltrials.gov provided by the National Institutes of Health, by the Regulatory Affairs Professionals Society (RAPS), the New York Times Coronavirus Vaccine Tracker, and by CNN Health.

Download the Covid-19 Vaccines report.

Includes promising Vaccines from:

Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Novavax, CansinoBio, Sinovac, Sinopharm, Medicago, Bharat Bio,Gamaleya

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Clinical Trials worldwide numbers for October 2020

Worldwide Covid-19 Clinical Trials numbers for October 2020

We continue to provide updated reports on Clinical Trials focused on Covid-19. Here is the update representing data from October 2020. Our reports are co-published with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

We will continue to publish Covid-19 Clinical Trial updates as data of new Trials are made available.

Download the Report.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Clinical Trials worldwide numbers for September

Worldwide Covid-19 Clinical Trials numbers for September

We continue to provide updated reports on Clinical Trials focused on Covid-19. Here is the update as of October 1st, representing data from September 2020. Our reports are co-published with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

We will continue to publish Covid-19 Clinical Trial updates as data of new Trials are made available.

Download the Report.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Clinical Trials worldwide for August

September update: Worldwide Covid-19 Coronavirus Clinical Trials

We continue to provide updated reports on Clinical Trials focused on Covid-19. Here is the update as of September 1st, representing data from August 2020. Our reports are co-published with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

We will continue to publish Covid-19 Clinical Trial updates as data of new Trials are made available.

Download the Covid-19 Worldwide Clinical Trial report, updated as of September 1st.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Clinical Trials worldwide for July

August update: Worldwide Covid-19 Coronavirus Clinical Trials

We continue to provide updated reports on Clinical Trials focused on Covid-19. Here is the update as of August 2nd, representing data from July 2020. Our reports are co-published with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

We will continue to publish Covid-19 Clinical Trial updates as data of new Trials are made available.

Download the Covid-19 Worldwide Clinical Trial report, updated as of August 2nd.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Clinical Trials around the World for May

June update: Worldwide Covid-19 Coronavirus Clinical Trials

We continue to provide updated reports on Clinical Trials focused on Covid-19. Our reports are co-published with our friends at the Clinical Research Organization, McDougall Scientific. We have taken clinical trial data directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

The number of Covid-19, coronavirus clinical trials has significantly grown since March. In April were about 1134 active Clinical Trials from around the world focused on Covid-19 and in May there were about 1703 trials from around the world, a 50% increase.

We will continue to publish Covid-19 Clinical Trial updates as data of new Trials are made available.

Download the Covid-19 Worldwide Clinical Trial report, updated as of June 1st.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Country
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Covid-19 Coronavirus Clinical Trials in Canada

Covid-19, Coronavirus Clinical Trials in Canada

With the pandemic of Covid-19 continuing across the globe, pharmaceutical companies, scientists, hospitals and health care organizations around the world continue to accelerate clinical research to find a treatment and possible vaccine. In Canada, the number of Covid-19, coronavirus clinical trials has been steadily growing.

As of May 1st, 2020, there were 29 active Clinical Trials operating in Canada focused on Covid-19. (See the report below).

Although Clinical Trials take time, we expect further growth over the next few months in the number of Clinical Trials for Covid-19 in Canada and around the world. We will publish any updates as data of new Clinical Trials are made available.

Health Canada has published certain guidelines as it pertains to the management of clinical trial applications (CTA) during the Covid-19 pandemic. Such guidelines include:

Health Canada will prioritize the review of clinical trial applications designed to investigate the diagnosis, treatment and/or prevention of COVID-19.
Sponsors may continue to file other CTA and CTA amendments according to Health Canada guidance.
During the course of a CTA review, if sponsors are unable to respond to an Information Request (IR) within specified time lines, consider withdrawing the submission without prejudice and refiling when the information is available.

Please visit Health Canada’s information page for further details on their guidelines for clinical trials during the Covid-19 pandemic.

Download the Covid-19 Clinical Trial in Canada summary report

We have co-published a report on Covid-19 Clinical Trials in Canada with our friends at the Clinical Research Organization (CRO) McDougall Scientific. We have taken clinical trial data for Canada directly from clinicaltrials.gov provided by the National Institutes of Health and published a summary of the data in a format that is hopefully useful to digest.

Some of the data provided includes:

# of Covid-19 Clinical Trials by Canadian Province
# of Covid-19 Clinical Trials by Sponsors/Collaborators
# of Covid-19 Clinical Trial by Drug Interventions

SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.